Production (Stage)
Zymeworks Inc.
ZYME
$11.54
$0.060.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.64% | 93.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.64% | 93.94% | |||
| Cost of Revenue | -3.57% | 1.95% | |||
| Gross Profit | -43.04% | 70.36% | |||
| SG&A Expenses | 4.94% | 16.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.99% | 6.06% | |||
| Operating Income | -15.29% | 35.05% | |||
| Income Before Tax | -24.44% | 39.94% | |||
| Income Tax Expenses | -91.32% | 2,428.76% | |||
| Earnings from Continuing Operations | 3.70% | 21.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.70% | 21.25% | |||
| EBIT | -15.29% | 35.05% | |||
| EBITDA | -19.76% | 40.30% | |||
| EPS Basic | 4.35% | 19.71% | |||
| Normalized Basic EPS | -23.64% | 38.77% | |||
| EPS Diluted | 3.65% | 19.84% | |||
| Normalized Diluted EPS | -23.59% | 38.79% | |||
| Average Basic Shares Outstanding | 0.68% | -1.93% | |||
| Average Diluted Shares Outstanding | 0.68% | -1.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||